About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

news

Company News Events Insights Webinars Virtual Tours

Congratulations to Dr. Junbo Wang & his team for winning the Best Collaboration Award of Luye Pharma in 2021

Dr. Junbo Wang & his team from BioDuro-Sundia’s Chemistry department won the ” Best Collaboration Award ” issued by Luye Pharma, in recognition of their ...
January 20, 2022

BioDuro-Sundia CEO gave a keynote speech at the 2022 J.P. Morgan Healthcare Conference!

Dr. Kent Payne, CEO of BioDuro-Sundia, highlighted the company's comprehensive CRDMO services at the 2022 J.P. Morgan Healthcare Conference in San Francisco
January 14, 2022

BioDuro-Sundia Receives 2021 Best Partner Award from Haihe Biopharma Drug Discovery Department

BioDuro-Sundia, awarded 2021 Best Partner by Haihe Biopharma, expands drug discovery with 1700+ staff across global R&D centers for comprehensive client support
January 06, 2022

BioDuro-Sundia Acquires 2nd US-based Commercial Drug Product Manufacturing Facility along with Commercial Supply Agreement

BioDuro-Sundia to acquire a fully-operational 45,000 ft2 commercial oral solid dose drug product manufacturing facility in Irvine, California | BioDuro-Sundia
November 08, 2021

Congratulations to Immunophage Biotech on the US FDA Approval to Initiate Clinical Trials for their Small Molecule MIF Inhibitor IPG1094

Congratulations to Immunophage Biotech on the US FDA Approval to Initiate Clinical Trials for their Small Molecule MIF Inhibitor IPG1094 | BioDuro-Sundia
August 27, 2021
Total 85 12345678...1617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all